Ripple Neuro

Salt Lake City, United States Founded: 2004 • Age: 22 yrs
Custom neuroscience tools and electrophysiology equipment are developed.

About Ripple Neuro

Ripple Neuro is a Healthcare company based in Salt Lake City (United States) founded in 2004. Custom neuroscience tools and electrophysiology equipment are developed. It operates on a Direct-to-Consumer (D2C) and Professional Services model in Healthcare and Technology sectors. Its Indian entity Rajasthan Polytex Private Limited reported revenue of β‚Ή8.86 Cr. Ripple Neuro offers products and services including Trek Processor, Nano2 and Nano2+Stim, Link R-32, Pico and Pico+Stim, and EMG Front End. Its focus areas include Medical Devices and Neuroscience Equipment. Its competitors include Neurovigil, Sanworks and Valero Dexterity Test; 1 of its 3 listed competitors has raised funding.

Company details

Ripple Neuro is focused on the development of custom neuroscience research tools and implantable technologies. Solutions are provided for non-human primate, small animal, and large animal applications, including brain-computer interfaces and closed-loop stimulation systems. The company is driven by a team of neuroscience researchers to support novel research in electrophysiology. Products such as portable wireless processors and real-time neural interface systems are designed and built in-house for optimized data acquisition and stimulation.

  • Headquarters Salt Lake City, United States
  • Sectors
    Healthcare
    Technology
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website rippleneuro.com
  • Social LinkedIn X YouTube
  • Legal Name Rajasthan Polytex Private Limited
  • Date of Incorporation 26 Apr, 1988
  • Jurisdiction Surat, Gujarat, India
Key Metrics
  • Indian entity revenue
    ₹8.86 Cr

    FY 2024 · -9% YoY

  • Indian entity net profit
    ₹6.8 Lakh

    FY 2024 · 1% margin

  • Indian entity EBITDA
    ₹1.25 Cr

    FY 2024 · 14% margin

  • Latest Funding Round
    $382.37K (USD), Grant

    Aug 2023

  • Investors

Products & Services of Ripple Neuro

Ripple Neuro offers a comprehensive portfolio of products and services, including Trek Processor, Nano2 and Nano2+Stim, Link R-32, Pico and Pico+Stim, and EMG Front End.

Trek Processor
Neuroscience Tools

Portable processor for wireless neuroscience data processing used.

Nano2 and Nano2+Stim
Neuroscience Tools

Front ends for animal electrophysiology studies are provided.

Link R-32
Implantable Technologies

Implantable device for wireless electrophysiology data is offered.

Pico and Pico+Stim
Neuroscience Tools

Small front ends for animal electrophysiology are designed.

EMG Front End
Neuroscience Tools

Device for multi-modal electrophysiology data acquisition is built.

Apps and channels of Ripple Neuro

its YouTube channel Ripple LLC has 23 subscribers and 7 videos.

Ripple LLC
YouTube 23 subscribers 7 videos Science & Technology
Open channel

Videos from Ripple Neuro

The most watched videos on Ripple Neuro's YouTube channel, Ripple LLC (23 subscribers). Click a video to play it here.

Ripple LLC: Custom Neuroscience Solutions
546 views
Neural Control of Movement - 2021 Virtual Demo
308 views
EEG and Multi-Modal Solutions
200 views
The Explorer Product Line for Human Neuroscience
172 views

More on Ripple LLC.

Funding Insights of Ripple Neuro

  • Total Rounds 12
  • Last Round Grant β€” $382,366
  • First Round $1.31M

    (Jul 2006)

  • Investors Count 1

Latest 10 of 12 funding rounds of Ripple Neuro with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Aug 2023$382,366Grant––
Sep 2020Grant––
Sep 2019$2.65MGrant––
Sep 2016$1.29MGrant––
Sep 2015$1.77MGrant––
Apr 2014$164,926Grant––
Apr 2014Grant––
Mar 2011$3.3MGrant––
Mar 2009$1.31MGrant––
Sep 2008$2.12MGrant––
Valuation history

1 investors in total: 1 institutional.

Investors in Ripple Neuro

Ripple Neuro has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Public health and human services are overseen by HHS.
1953hhs.gov
Premium access

Investor details for Ripple Neuro

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Rajasthan Polytex Private Limited (Ripple Neuro)

Rajasthan Polytex Private Limited is the primary company behind Ripple Neuro. The board of Rajasthan Polytex Private Limited currently have 2 directors; the longest-serving is Madan Mohan Periwal, appointed in 1993. 2 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Madan Mohan Periwal
DIN 00115136
Director06 Dec 199332 yrs 10 moRajasthan Polytex Private Limited
Priyeshkumar Madanmohan Periwal
DIN 06362891
Director01 Oct 201115 yrs 1 moRajasthan Polytex Private Limited

Financials of Ripple Neuro

Figures of Rajasthan Polytex Private Limited, the primary company behind Ripple Neuro, for FY 2024. Revenue was ₹8.86 Cr (-9% year on year). Net profit was ₹6.8 Lakh (1% margin). EBITDA was ₹1.25 Cr (14% margin). Revenue has grown at a compounded annual rate of +26% over three years and +2% over five years.

  • ₹8.86 CrRevenue · FY 2024 · -9% YoY
  • ₹6.8 LakhNet profit · 1% margin
  • ₹1.25 CrEBITDA · 14% margin
  • ₹2.00 CrPaid-up capital
  • 6Employees (provident fund records)
  • +26%Revenue CAGR, 3 years
  • +2%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Rajasthan Polytex Private Limited are on its company page.

Premium access

Detailed financial statements for Ripple Neuro

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of Ripple Neuro

3 dated milestones of Ripple Neuro across 19 years, from founding to its latest funding, stage changes and deals.

  1. Founded Ripple Neuro is founded.
  2. Funding First funding round of $1.3M.
  3. Funding Latest funding round, Grant, of $382K.

Competitors of Ripple Neuro

Ripple Neuro has 3 listed competitors in our database, 1 of them funded. They include Neurovigil, Sanworks and Valero Dexterity Test.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
neurovigil.com2007Mountain View, United States$250,000
Solution provider for analysis of brain data in medical applications
sanworks.io2016Sound Beach, United States
Open systems to connect brain function with behavior
valerodexterity.com2020Glendale, United States
Provides neuromuscular testing device for medical and athletic assessments.
Premium access

Detailed competitors of Ripple Neuro

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Ripple Neuro

The website of Ripple Neuro (rippleneuro.com) receives about 4.4K visits a month.

  • Monthly visits
    4.4K

    ▲ 8.9% vs previous month

Similar websites

Websites whose visitors overlap most with Ripple Neuro. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
rippleneuromed.com
100%
#10,447,084View details

Top companies in Neurology

3 companies that operate in the same segment as Ripple Neuro (Neurology) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed.
2013San Francisco, California, United StatesUSD 214.78 MUSD 21.05 M211
Developer of therapeutics for psychiatric and neurologic diseases
2002New York, New York, United StatesUSD 80.87 MUSD 250.31 M600
Biologics platform developed for intracellular delivery in rare diseases.
2016Boston, Massachusetts, United StatesUSD 175.25 MUSD 25.42 M183
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Ripple Neuro

Ripple Neuro was founded in 2004 and raised its 1st funding round 2 years after it was founded.

Ripple Neuro is headquartered in Salt Lake City, United States. It is registered at Salt Lake City, Utah, United States.

The primary company behind Ripple Neuro, Rajasthan Polytex Private Limited, reported revenue of β‚Ή8.86 Cr for FY 2024, down 9% year on year.

Ripple Neuro is focused on the development of custom neuroscience research tools and implantable technologies. Solutions are provided for non-human primate, small animal, and large animal applications, including brain-computer interfaces and closed-loop stimulation systems. The company is driven by a team of neuroscience researchers to support novel research in electrophysiology. Products such as portable wireless processors and real-time neural interface systems are designed and built in-house for optimized data acquisition and stimulation.

Ripple Neuro's top competitors include Neurovigil, Sanworks and Valero Dexterity Test.

Ripple Neuro offers Trek Processor, Nano2 and Nano2+Stim, Link R-32, Pico and Pico+Stim, and EMG Front End.

Ripple Neuro has 1 investor. Key investors include HHS.

Ripple Neuro operates through Rajasthan Polytex Private Limited.

The legal entities of Ripple Neuro currently have 2 directors, including Madan Mohan Periwal, Priyeshkumar Madanmohan Periwal.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available